Home Indication Prioritization and Opportunity Selection

Quick overview

Our client needed support for the identification and selection of opportunities to grow and optimize its offerings. Business opportunities in multiple indications were evaluated based on growth potential, client’s current capabilities, and gaps in the portfolio. The complex findings were used as an input to present it through our proprietary “risk and return trade-off matrix” tool. The insights were used to prioritize the opportunities and develop new products targeting Rare diseases, Pain, and Inflammation.

Client success details

The client narrowed its focus on the selected high potential indications/subindication from the opportunity canvas. The innovator determined the sequence of opportunities, and built a future road map based on different scenarios and synergies. FutureBridge enabled client in decision making by addressing following key business questions through robust research methodology.

Li-Ion batteries are the main core of the electric vehicle segment and developing manufacturing capability is very important to gain competitive advantages.
  • How is the innovation evolving for different indications?
  • Which indications and sub-indications are most attractive from a commercial, innovation, competition standpoint
  • What are the major unmet needs in the market?
  • What is the level of competition in each area of opportunity?
  • What is the returns Vs risks proposition for each indication?
  • How the current attractiveness would change over time?




FutureBridge conducted a structured secondary research and focused group discussions across the therapeutic value chain. This included:

  • Systematic literature review and a detailed pre-clinical, clinical trials, and patent landscape across multiple therapeutic areas and indications
  • Treatment guideline, architecture, and Patient journey mapping across the indications. Comprehensive map of present and future competitive framework
  • Custom benchmarking methodology for the opportunity, innovation, and disease burden
  • Primary research with multiple stakeholders in the value chain – Detailed Interviews
  • Focused group discussion with participants from the complete value chain

FutureBridge provided support to the client to access scientific proof to prioritize and benchmark indications to focus and design strategy for the next decade in a complex therapeutic segment.

FutureBridge continued to support the client by shortlisting potential candidates for the next level of partnering and acquisition assessment and due diligence. In addition, the comprehensive exercise also triggered multiple continuous competition monitoring projects designed specifically for the priority & strategic therapeutic segments.

Need a thought partner?

Share your focus area or question to engage with our Analysts through the Business Objectives service.

Submit My Business Objective

Our Clients

Our long-standing clients include some of the worlds leading brands and forward-thinking corporations.

New Feature

Login with your mobile number. Update now.